Clinical End-Points Associated with <i>Mycobacterium
tuberculosis</i> and Lung Cancer: Implications into Host-Pathogen Interaction and Coevolution

<div>Higher presence of MTB/MTB-L in the lung cancer samples compared to samples of other cancer types by both the IK method and the<i> mpb64</i> marker.</div>

BioMed Research International

fig4

Figure 4

Figure 4: Clinical End-Points Associated with <i>Mycobacterium
tuberculosis</i> and Lung Cancer: Implications into Host-Pathogen Interaction and Coevolution 

Figure 4 | Clinical End-Points Associated with Mycobacterium
tuberculosis and Lung Cancer: Implications into Host-Pathogen Interaction and Coevolution 

BioMed Research International

Clinical End-Points Associated with Mycobacterium tuberculosis and Lung Cancer: Implications into Host-Pathogen Interaction and Coevolution

Figure 4